WILMINGTON, Mass., Feb. 6, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the 14th Annual BIO CEO & Investor Conference. The conference is being held at the Waldorf Astoria Hotel in New York on February 13-14, 2012. Mr. Doman is scheduled to present at 2:30 p.m. EST on February 14, 2012. Interested parties can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website approximately three hours following the presentation.
